Excellent overall and chronic graft-versus-host-disease-free event-free survival in Fanconi anaemia patients undergoing matched related- and unrelated-donor bone marrow transplantation using alemtuzumab-Flu-Cy: the UK experience
Contributeurs/tricesBernard, Fanette![orcid](assets/images/orcid.png)
; Uppugunduri Satyanarayana, Chakradhara Rao![orcid](assets/images/orcid.png)
; Meyer, Stephan; Cummins, Michelle; Patrick, Katharine; James, Beki; Skinner, Roderick; Tewari, Sanjay; Carpenter, Ben; Wynn, Robert; Veys, Paul; Amrolia, Persis; the UK Paediatric BMT group
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
Publié dansBritish journal of haematology, vol. 193, no. 4, p. 804-813
Date de publication2021-05
Date de mise en ligne2021-04-14
Résumé
Mots-clés
- Adolescent
- Adult
- Alemtuzumab / administration & dosage
- Allografts
- Bone Marrow Transplantation
- Child
- Child, Preschool
- Chronic Disease
- Cyclophosphamide / administration & dosage
- Disease-Free Survival
- Fanconi Anemia / mortality
- Fanconi Anemia / therapy
- Female
- Follow-Up Studies
- Graft vs Host Disease / mortality
- Graft vs Host Disease / prevention & control
- Humans
- Male
- Retrospective Studies
- Survival Rate
- Transplantation Conditioning
- Unrelated Donors
Structure d'affiliation
Groupe de recherche
Citation (format ISO)
BERNARD, Fanette et al. Excellent overall and chronic graft-versus-host-disease-free event-free survival in Fanconi anaemia patients undergoing matched related- and unrelated-donor bone marrow transplantation using alemtuzumab-Flu-Cy: the UK experience. In: British journal of haematology, 2021, vol. 193, n° 4, p. 804–813. doi: 10.1111/bjh.17418
Fichiers principaux (1)
Article (Published version)
![accessLevelRestricted](assets/images/access-level-restricted.png)
Identifiants
- PID : unige:158618
- DOI : 10.1111/bjh.17418
- PMID : 33855694
URL commercialhttps://onlinelibrary.wiley.com/doi/10.1111/bjh.17418
ISSN du journal0007-1048